HCW Biologics Inc. (HCWB)
2.43
-0.08
(-3.19%)
USD |
NASDAQ |
Sep 09, 10:30
HCW Biologics Price : 2.43 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 2.52 | 2.72 | 2.10 | 2.51 | 3.088M |
| Sep 04, 2026 | 2.81 | 2.97 | 2.80 | 2.94 | 37298.00 |
| Sep 03, 2026 | 3.34 | 3.34 | 2.700 | 2.87 | 127591.0 |
| Sep 02, 2026 | 3.54 | 3.81 | 3.32 | 3.355 | 210751.0 |
| Sep 01, 2026 | 3.51 | 3.73 | 3.30 | 3.45 | 545878.0 |
| Aug 31, 2026 | 3.60 | 3.60 | 3.210 | 3.59 | 59017.00 |
| Aug 28, 2026 | 3.20 | 3.43 | 3.00 | 3.43 | 127564.0 |
| Aug 27, 2026 | 2.70 | 3.28 | 2.60 | 3.17 | 337620.0 |
| Aug 26, 2026 | 2.69 | 2.70 | 2.55 | 2.70 | 62385.00 |
| Aug 25, 2026 | 2.31 | 2.888 | 2.28 | 2.60 | 281815.0 |
| Aug 24, 2026 | 2.32 | 2.323 | 2.15 | 2.31 | 308041.0 |
| Aug 21, 2026 | 2.16 | 2.23 | 2.05 | 2.18 | 55858.00 |
| Aug 20, 2026 | 2.26 | 2.38 | 2.06 | 2.12 | 90092.00 |
| Aug 19, 2026 | 2.14 | 2.400 | 2.13 | 2.30 | 111857.0 |
| Aug 18, 2026 | 2.52 | 3.05 | 2.05 | 2.13 | 1.237M |
| Aug 17, 2026 | 2.68 | 2.896 | 2.47 | 2.52 | 59927.00 |
| Aug 14, 2026 | 3.185 | 3.25 | 2.580 | 2.68 | 130404.0 |
| Aug 13, 2026 | 3.08 | 3.27 | 2.85 | 2.925 | 52529.00 |
| Aug 12, 2026 | 3.21 | 3.301 | 3.090 | 3.145 | 55925.00 |
| Aug 11, 2026 | 3.30 | 3.43 | 3.13 | 3.17 | 25829.00 |
| Aug 10, 2026 | 3.44 | 3.67 | 3.24 | 3.27 | 39279.00 |
| Aug 07, 2026 | 3.41 | 3.57 | 3.30 | 3.41 | 51907.00 |
| Aug 06, 2026 | 3.45 | 3.53 | 3.20 | 3.41 | 48635.00 |
| Aug 05, 2026 | 3.69 | 3.69 | 3.07 | 3.43 | 47905.00 |
| Aug 04, 2026 | 3.59 | 3.69 | 3.41 | 3.60 | 67905.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 85.00 |
| Oncolytics Biotech, Inc. | 0.813 |
| Sangamo Therapeutics, Inc. | 0.1609 |
| Sarepta Therapeutics, Inc. | 22.62 |
| Anixa Biosciences, Inc. | 2.85 |
Price Related Metrics
| PS Ratio | 0.2868 |
| Price to Book Value | 0.5292 |
| Earnings Yield | -1.17K% |
| Market Cap | 3.931M |